Current Insights on the Role of Irisin in Endothelial Dysfunction

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Metabolic Disorders

Background:

• Endothelial dysfunction is a key factor in cardiovascular diseases, often driven by metabolic issues.
• Irisin, an adipomyokine, offers metabolic benefits like improved insulin sensitivity and reduced inflammation.
• Preclinical studies suggest irisin protects endothelial cells via multiple molecular pathways.

Purpose of the Study:

• To review and integrate preclinical and clinical findings on irisin's role in endothelial dysfunction.
• To elucidate the mechanisms and pathways involved in irisin's potential preventive effects.
• To address the controversial clinical evidence regarding irisin and endothelial health.

Main Methods:

• Comprehensive literature review of preclinical models and clinical studies.
• Comparative analysis of studies investigating irisin's effects on endothelial function.
• Integration of data to synthesize current knowledge on irisin's mechanisms.

Main Results:

• Preclinical data indicate irisin reduces oxidative stress, enhances vasodilation, and promotes cell survival.
• Clinical studies present conflicting results, with some showing protective associations and others linking irisin to increased atherosclerosis risk.
• Evidence for irisin's protective role in human endothelial dysfunction remains inconclusive.

Conclusions:

• The precise role of irisin in human endothelial dysfunction requires further investigation.
• Understanding irisin's pathways could reveal novel therapeutic targets for cardiovascular diseases.
• Reconciling preclinical findings with clinical observations is crucial for irisin's therapeutic potential.